FDA Approves New Interchangeable Biosimilar to Pertuzumab By Ogkologos - December 3, 2025 367 0 Facebook Twitter Google+ Pinterest WhatsApp Approval is based on comparisons across a broad range of structural and functional product quality attributes Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Baby Boy Can’t Stop Smiling After Surgery Allows Him To See... September 18, 2019 Fewer Women with Ovarian, Breast Cancer Undergo Genetic Testing than Expected April 9, 2019 Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women... January 18, 2022 Grandma Who Sent Accidental Text To Stranger Spends 6th Thanksgiving With... December 1, 2021 Load more HOT NEWS Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated... New chemotherapy-free treatment for bowel cancer made available in Scotland Concurrent Intrathecal and Intravenous Nivolumab is Safe and Feasible with Preliminary...
